Lesley Rhee

4.2k total citations · 2 hit papers
13 papers, 3.5k citations indexed

About

Lesley Rhee is a scholar working on Immunology, Genetics and Cancer Research. According to data from OpenAlex, Lesley Rhee has authored 13 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Genetics and 4 papers in Cancer Research. Recurrent topics in Lesley Rhee's work include T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (4 papers) and NF-κB Signaling Pathways (4 papers). Lesley Rhee is often cited by papers focused on T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (4 papers) and NF-κB Signaling Pathways (4 papers). Lesley Rhee collaborates with scholars based in United States, Canada and Portugal. Lesley Rhee's co-authors include Deborah J. Lenschow, J A Bluestone, Benoı̂t L. Salomon, Bhagirath Singh, Arlene H. Sharpe, Kevan C. Herold, Jeffrey A. Bluestone, G S Gray, Husain Sattar and Shu‐Chuan Ho and has published in prestigious journals such as The Journal of Experimental Medicine, Immunity and The Journal of Immunology.

In The Last Decade

Lesley Rhee

13 papers receiving 3.5k citations

Hit Papers

B7/CD28 Costimulation Is Essential for the Homeostasis of... 1995 2026 2005 2015 2000 1995 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes
    2000 1.7k citations Benoı̂t L. Salomon, Deborah J. Lenschow et al. Immunity profile →
  2. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.
    1995 518 citations Deborah J. Lenschow, Shu‐Chuan Ho et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lesley Rhee United States 11 2.9k 852 424 364 291 13 3.5k
Melissa E. Elder United States 19 1.3k 0.4× 606 0.7× 321 0.8× 152 0.4× 710 2.4× 48 2.4k
Ryoji Yasumizu Japan 23 1.4k 0.5× 305 0.4× 271 0.6× 248 0.7× 352 1.2× 81 2.4k
Benedict Seddon United Kingdom 32 3.6k 1.2× 337 0.4× 724 1.7× 388 1.1× 678 2.3× 75 4.4k
Mark W. Appleby United States 17 2.9k 1.0× 548 0.6× 661 1.6× 188 0.5× 849 2.9× 24 3.8k
Richard J. DiPaolo United States 30 2.6k 0.9× 281 0.3× 635 1.5× 462 1.3× 611 2.1× 66 3.6k
Pablo A. Silveira Australia 22 1.4k 0.5× 763 0.9× 201 0.5× 435 1.2× 196 0.7× 57 2.0k
Tomohide Yamazaki United States 16 2.7k 0.9× 368 0.4× 1.6k 3.8× 221 0.6× 399 1.4× 20 3.5k
Leigh A. Stephens United Kingdom 17 1.8k 0.6× 443 0.5× 295 0.7× 274 0.8× 249 0.9× 18 2.2k
Gisela Orozco United Kingdom 31 1.3k 0.4× 624 0.7× 264 0.6× 148 0.4× 764 2.6× 75 2.6k
Marc Martínez‐Llordella United Kingdom 25 2.6k 0.9× 337 0.4× 567 1.3× 884 2.4× 585 2.0× 42 4.2k

Countries citing papers authored by Lesley Rhee

Since Specialization
Citations

This map shows the geographic impact of Lesley Rhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Rhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Rhee more than expected).

Fields of papers citing papers by Lesley Rhee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley Rhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Rhee. The network helps show where Lesley Rhee may publish in the future.

Co-authorship network of co-authors of Lesley Rhee

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley Rhee. A scholar is included among the top collaborators of Lesley Rhee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley Rhee. Lesley Rhee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Abernathy‐Close, Lisa, et al.. (2018). The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis. Mucosal Immunology. 11(5). 1454–1465. 10 indexed citations
2.
Murphy, Stephen F., Lesley Rhee, Wesley A. Grimm, et al.. (2014). Intestinal epithelial expression of TNFAIP3 results in microbial invasion of the inner mucus layer and induces colitis in IL-10-deficient mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 307(9). G871–G882. 17 indexed citations
3.
4.
Rhee, Lesley, Stephen F. Murphy, Wesley A. Grimm, et al.. (2012). Expression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 303(2). G220–G227. 24 indexed citations
5.
Lodolce, James P., Lesley Rhee, Silvia N. Kariuki, et al.. (2010). African-Derived Genetic Polymorphisms in TNFAIP3 Mediate Risk for Autoimmunity. The Journal of Immunology. 184(12). 7001–7009. 77 indexed citations
6.
Salloum, Rafah, Beverly S. Franek, Silvia N. Kariuki, et al.. (2010). Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon‐α activity in lupus patients. Arthritis & Rheumatism. 62(2). 553–561. 121 indexed citations
7.
Tavares, Rita M., Emre E. Turer, Rommel Advincula, et al.. (2010). The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity. Immunity. 33(2). 181–191. 201 indexed citations
8.
Salomon, Benoı̂t L., Lesley Rhee, H Bour, et al.. (2001). Development of Spontaneous Autoimmune Peripheral Polyneuropathy in B7-2–Deficient Nod Mice. The Journal of Experimental Medicine. 194(5). 677–684. 176 indexed citations
9.
Girvin, Ann M., Mauro C. Dal Canto, Lesley Rhee, et al.. (2000). A Critical Role for B7/CD28 Costimulation in Experimental Autoimmune Encephalomyelitis: A Comparative Study Using Costimulatory Molecule-Deficient Mice and Monoclonal Antibody Blockade. The Journal of Immunology. 164(1). 136–143. 133 indexed citations
10.
Salomon, Benoı̂t L., Deborah J. Lenschow, Lesley Rhee, et al.. (2000). B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes. Immunity. 12(4). 431–440. 1702 indexed citations breakdown →
11.
Lenschow, Deborah J., Kevan C. Herold, Lesley Rhee, et al.. (1996). CD28/B7 Regulation of Th1 and Th2 Subsets in the Development of Autoimmune Diabetes. Immunity. 5(3). 285–293. 315 indexed citations
12.
Lenschow, Deborah J., Shu‐Chuan Ho, Husain Sattar, et al.. (1995). Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.. The Journal of Experimental Medicine. 181(3). 1145–1155. 518 indexed citations breakdown →
13.
Lenschow, Deborah J., Anne I. Sperling, Michael P. Cooke, et al.. (1994). Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen.. The Journal of Immunology. 153(5). 1990–1997. 254 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa E. Elder Breakdown of academic impact, for papers by Ryoji Yasumizu Breakdown of academic impact, for papers by Benedict Seddon Breakdown of academic impact, for papers by Mark W. Appleby Breakdown of academic impact, for papers by Richard J. DiPaolo Breakdown of academic impact, for papers by Pablo A. Silveira Breakdown of academic impact, for papers by Tomohide Yamazaki Breakdown of academic impact, for papers by Leigh A. Stephens Breakdown of academic impact, for papers by Gisela Orozco Breakdown of academic impact, for papers by Marc Martínez‐Llordella
Rankless by CCL
2026